FDAClass IJune 25, 2025

Umovy Acido Hialuronico recall

UMOVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7503046054134

Why was Umovy Acido Hialuronico recalled?

Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

All Lots; All Expiration Dates.

Product
UMOVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7503046054134
Recalling firm
Umary-USA.com
Quantity
1,704 30-count bottles
Distribution
U.S. Nationwide via internet.
Recall date
June 25, 2025
Classification
Class I
Status
Completed
Agency
FDA (drug)
Open FDA enforcement record Latest recalls